- Biden Warns of 500,000 COVID Deaths by February
- Health Highlights: Jan. 22, 2021
- For Rising Number of People, Obesity Is a Literal Headache
- Even When Cancer Is in Remission, Patients’ Risks of Severe COVID Rise
- Exercise Doesn’t Boost Health If You Stay Obese, Study Finds
- Immune System May ‘Remember’ Infections From Previous Coronaviruses
- You’re More Likely to Maintain Social Distance If Your Friends Do: Study
- Meth Overdose Deaths Are Surging in America, With Minorities Most at Risk
- Maybe Money Can Help Buy Happiness, After All
- Will Vaccines Work Against the New Coronavirus Variants?
Clinical Trials Update: Aug. 20, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Memory Loss
This study of an investigational drug is for adults with memory loss or mild cognitive impairment. Participants will receive study-related medical care, study medication and evaluations.
The research site is in Norwich, Conn.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/memory_loss.aspx.
—–
Epilepsy
This study is for people who have epilepsy and have had epileptic episodes. Participants will receive study medication, study-related physical exams, laboratories, EKGs (all at no cost), and compensation for time and travel.
The research site is in Houston, Texas.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/epilepsy.aspx.
—–
Hot Flashes
This study seeks female volunteers, aged 35 to 60, who have hot flashes. The study will last approximately eight weeks and consist of five office visits.
The research site is in Charleston, S.C.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/hot_flashes.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
